Obesity in Patients with COVID-19

Obesity raises the likelihood of hospitalisation, ICU admission, IMV therapy, and death in COVID-19 patients. Furthermore, excessive visceral adiposity appears to be connected to poor COVID-19 outcomes. These findings highlight the importance of individuals, the general public, and governments taking effective measures to raise awareness of the hazards associated with obesity and how they are exacerbated in the current worldwide epidemic. Obesity is frequent among coronavirus patients in 2019 (COVID-19). Obesity's impact on COVID-19 clinical outcomes warrants further investigation.

  • Coronavirus disease 2019
  • Intensive care
  • Mortality
  • Obesity
  • Visceral adipose tissue

Related Conference of Obesity in Patients with COVID-19

March 13-14, 2025

8th International Conference on Obesity and Chronic Diseases

Prague, Czech Republic
March 24-25, 2025

27th Global Obesity Meeting

London, UK
April 17-18, 2025

5th World Summit on Obesity and Weight Management

Madrid, Spain
June 02-03, 2025

21st Euro Obesity and Endocrinology Congress

Amsterdam, Netherlands

Obesity in Patients with COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in